Abstract:Purpose: Both polymer micelles and mesoporous silica nanoparticles have been widely researched as vectors for small molecular insoluble drugs. To combine the advantages of copolymers and silica, studies on the preparation of copolymer-silica composites and cellular evaluation were carried out. Methods: First, a stearic acid-g-chitosan (CS-SA) copolymer was synthesized through a coupling reaction, and then silicone oxide (SiO2)-deposited doxorubicin (DOX)-loaded stearic acid-g-chitosan (CS-SA/SiO2/DOX) nanoparticles were prepared through the sol-gel reaction. Physical and chemical properties such as particle size, zeta potential, and morphologies were examined, and small-angle X-ray scattering (SAXS) analysis was employed to identify the mesoporous structures of the generated nanoparticles. Cellular uptake and cytotoxicity studies were also conducted. Results: CS-SA/SiO2/DOX nanoparticles with different amounts of SiO2 deposited were obtained, and SAXS studies showed that mesoporous structures existed in the CS-SA/SiO2/DOX nanoparticles. The mesoporous size of middle-ratio and high-ratio deposited CS-SA/SiO2/DOX nanoparticles were 4-5 nm and 8-10 nm, respectively. Based on transmission electron microscopy images of CS-SA/SiO2/DOX nanoparticles, dark rings around the nanoparticles could be observed in contrast with CS-SA/DOX micelles. Furthermore, CS-SA/SiO2/DOX nanoparticles exhibited faster release behavior in vitro than CS-SA/DOX micelles; cellular uptake research in A549 indicated that the CS-SA/SiO2/DOX nanoparticles were taken up by A549 cells more rapidly, and that CS-SA/SiO2/DOX nanoparticles entered the cell more easily when the amount of SiO2 was higher. IC50 values of CS-SA/DOX micelles, CS-SA/SiO2/DOX-4, CS-SA/SiO2/DOX-8, and CS-SA/SiO2/DOX-16 nanoparticles against A549 cells measured using the MTT assay were 1.69, 0.93, 0.32, and 0.12 mu g/mL, respectively. Conclusion: SiO2-deposited stearic acid-g-chitosan organic-inorganic composites show promise as nanocarriers for hydrophobic drugs such as DOX.

Chitosan oligosaccharide-arachidic acid-based nanoparticles for anti-cancer drug delivery

Nanoparticles of deoxycholic acid, polyethylene glycol and folic acid-modified chitosan for targeted delivery of doxorubicin

Chitosan/o-carboxymethyl Chitosan Nanoparticles for Efficient and Safe Oral Anticancer Drug Delivery: in Vitro and in Vivo Evaluation.

Ph-Sensitive Chitosan-Derived Nanoparticles As Doxorubicin Carriers for Effective Anti-Tumor Activity: Preparation and in Vitro Evaluation.

Synthesis and in Vitro Characterization of Carboxymethyl Chitosan-CBA-Doxorubicin Conjugate Nanoparticles As Ph-Sensitive Drug Delivery Systems

ARGININE- AND ACRYLONITRILE-MODIFIED CHITOSAN NANOPARTICLES FOR ANTICANCER DRUG DELIVERY

Redox-responsive polymer-drug conjugates based on doxorubicin and chitosan oligosaccharide-g-stearic acid for cancer therapy.

Self-Assembled Nanoparticles Based on Galactosylated O-Carboxymethyl Chitosan-Graft-Stearic Acid Conjugates for Delivery of Doxorubicin

Hollow chitosan-silica nanospheres for doxorubicin delivery to cancer cells with enhanced antitumor effect in vivo

Synthesis and Antitumor Activity of Doxorubicin Conjugated Stearic Acid-G-chitosan Oligosaccharide Polymeric Micelles

Cellular Uptake and Cytotoxicity of Shell Crosslinked Stearic Acid-Grafted Chitosan Oligosaccharide Micelles Encapsulating Doxorubicin.

Self-assembled micelles based on Chondroitin sulfate/poly (d,l-lactideco-glycolide) block copolymers for doxorubicin delivery

Amphiphilically modified chitosan cationic nanoparticles for drug delivery

Synthesis and characterization of amphiphilic glycidol-chitosan-deoxycholic acid nanoparticles as a drug carrier for doxorubicin.

Ph-Sensitive Deoxycholic Acid Dimer for Improving Doxorubicin Delivery and Antitumor Activity in Vivso.

Sodium Dodecyl Sulfate-Modified Doxorubicin-Loaded Chitosan-Lipid Nanocarrier with Multi Polysaccharide-Lecithin Nanoarchitecture for Augmented Bioavailability and Stability of Oral Administration in Vitro and in Vivo.

Self-assembled Nanoparticles Based on Hydrophobically Modified Chitosan As Carriers for Doxorubicin.

Preparation and characteristics of linoleic acid-grafted chitosan oligosaccharide micelles as a carrier for doxorubicin.

Preparation and evaluation of SiO2-deposited stearic acid-g-chitosan nanoparticles for doxorubicin delivery.

Synthesis and Evaluation of Ph-Sensitive, Self-Assembled Chitosan-Based Nanoparticles As Efficient Doxorubicin Carriers

Investigation of Polymeric Amphiphilic Nanoparticles As Antitumor Drug Carriers